Cargando…
Analysis of risk factors associated with survival in human epidermal growth factor receptor 2-positive ductal carcinoma in situ using Korean Breast Cancer Society Database
PURPOSE: This study was performed to identify the risk of mortality in patients diagnosed with human epidermal growth factor receptor 2 (HER2)-positive ductal carcinoma in situ (DCIS). METHODS: We selected 2,592 patients with HER2-positive DCIS from Korean Breast Cancer Society (KBCS) database betwe...
Autores principales: | Ahn, Sol Ji, Yoon, Chang Ik, Paik, Pill Sun, Yoo, Tae-Kyung, Park, Namsun, Lee, Eun Sook, Choi, Jung Eun, Jeong, Joon, Youn, Hyun Jo, Park, Woo-Chan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Surgical Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651984/ https://www.ncbi.nlm.nih.gov/pubmed/34934758 http://dx.doi.org/10.4174/astr.2021.101.6.315 |
Ejemplares similares
-
Low incidence of lymph node metastasis in patients with microinvasive breast cancer: a Korean nationwide study
por: Paik, Pill Sun, et al.
Publicado: (2022) -
CORRIGENDUM: Correction of the first author’s affiliation. Low incidence of lymph node metastasis in patients with microinvasive breast cancer: a Korean nationwide study
por: Paik, Pill Sun, et al.
Publicado: (2022) -
MRI of the Breast for the Detection and Assessment of the Size of Ductal Carcinoma in Situ
por: Kim, Do Youn, et al.
Publicado: (2007) -
Ductal carcinoma in situ: a risk prediction model for the underestimation of invasive breast cancer
por: Park, Ko Woon, et al.
Publicado: (2022) -
Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human Epidermal Growth Factor Receptor 2-Subtype Squamous Cell Carcinoma
por: An, Jeongshin, et al.
Publicado: (2019)